搜索临床试验以:5 型磷酸二酯酶抑制剂 (PDE5I)
总计6688个结果
-
Johnson & Johnson Pharmaceutical Research & Development...完全的性功能障碍 | 勃起功能障碍法国, 波兰, 美国, 比利时, 墨西哥, 马来西亚, 加拿大, 台湾, 大韩民国, 俄罗斯联邦, 阿根廷, 澳大利亚, 英国
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers University完全的
-
National Heart, Lung, and Blood Institute (NHLBI)终止
-
Inje University完全的健康受试者 | 三种 PDE5I 的药代动力学 | 遗传多态性 CYP3A5
-
The Nazareth HospitalWestern Galilee Hospital-Nahariya未知
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center完全的
-
Asan Medical CenterDong-A Pharmaceutical Co., Ltd.完全的
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI)未知
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart Network完全的
-
Asan Medical CenterSK Chemicals Co., Ltd.完全的
-
Dong-A ST Co., Ltd.完全的
-
Kyungpook National University Hospital完全的
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Seoul National University HospitalDong-A PharmTech Co., Ltd.完全的
-
Dong-A Pharmaceutical Co., Ltd.完全的
-
Samsung Medical CenterDong-A Pharmaceutical Co., Ltd.未知
-
University of North Carolina, Chapel HillEli Lilly and Company; University of Cincinnati; United Therapeutics完全的
-
Eli Lilly and Company完全的
-
The Catholic University of KoreaHanmi Pharmaceutical Company Limited未知
-
Christoph HornikNational Heart, Lung, and Blood Institute (NHLBI); University of North Carolina, Chapel Hill招聘中